Coya Therapeutics, Inc. (COYA)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Mar. 19, 2026 | CORRESP | Neutral/Informational | High | Coya Therapeutics, Inc. has submitted a request to the SEC for the immediate effectiveness of their Registration Statement on Form S-3. The company is seeking to have the statemen… | Read Filing EDGAR |
| Mar. 19, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Coya Therapeutics, Inc. that it will not review their registration statement filed on March 16, 2026. The letter emphasizes the company's responsibilit… | Read Filing EDGAR |
| Aug. 18, 2025 | CORRESP | Neutral/Informational | Moderate | Coya Therapeutics, Inc. has submitted a request for the acceleration of the effectiveness of their Registration Statement on Form S-3. They are seeking to have the statement decla… | Read Filing EDGAR |
| Aug. 13, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated August 13, 2025, informs Coya Therapeutics, Inc. that their registration statement on Form S-3, filed on August 12, 2025, will not be reviewed by the … | Read Filing EDGAR |